(QBTS) D-Wave Quantum - NYSE
Sector: Technology | Industry: Computer Hardware | Exchange: NYSE (USA) | Market Cap: 8.657m USD | Total Return: 54.1% in 12m
Avg Turnover: 913M
Qual. Beats: 0
Rev. Trend: 77.9%
Qual. Beats: 0
Warnings
Share dilution 28.3% YoY
High Debt while negative Cash Flow
Interest Coverage Ratio -15.0 is critical
Beneish M-Score 1.00 > -1.5 - likely earnings manipulation
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
D-Wave Quantum Inc. (NYSE: QBTS) specializes in the development and delivery of quantum computing hardware, software, and cloud-based services. The company’s primary offerings include the Advantage and Advantage 2 quantum annealing systems, the Leap quantum cloud platform, and the Ocean software development kit. These tools are designed to facilitate real-time access to quantum-classical hybrid solvers for enterprise-scale optimization problems.
The company focuses on commercial applications such as logistics optimization, drug discovery, and financial portfolio management. Unlike gate-model quantum computers, D-Wave’s annealing technology is specifically engineered to solve complex combinatorial optimization tasks by finding the lowest energy state of a given system. The quantum computing sector is currently characterized by a transition from experimental research to quantum utility, where systems are integrated into existing classical workflows to improve computational efficiency.
Investors can find further data-driven insights on these industry trends at ValueRay. Founded in 1999 and headquartered in Palo Alto, California, D-Wave operates as a pure-play provider in the emerging quantum infrastructure market.
- Leap cloud service subscription growth drives recurring revenue and margin expansion
- Enterprise adoption of annealing quantum systems for industrial logistics optimization
- Federal government funding and procurement cycles for high-performance computing infrastructure
- Cash burn rate and liquidity position influence equity dilution risk
- Commercial deployment milestones for Advantage 2 system validate technological roadmap
| Net Income: -368.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.28 > 0.02 and ΔFCF/TA 7.30 > 1.0 |
| NWC/Revenue: 4.65k% < 20% (prev 1.38k%; Δ 3.27k% < -1%) |
| CFO/TA -0.08 > 3% & CFO -97.7m > Net Income -368.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 21.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (367.5m) vs 12m ago 28.30% < -2% |
| Gross Margin: 66.27% > 18% (prev 83.23%; Δ -16.96% > 0.5%) |
| Asset Turnover: 1.63% > 50% (prev 6.56%; Δ -4.93% > 0%) |
| Interest Coverage Ratio: -15.02 > 6 (EBIT TTM -143.8m / Interest Expense TTM 9.57m) |
| A: 0.48 (Total Current Assets 607.1m - Total Current Liabilities 28.4m) / Total Assets 1.20b |
| B: -0.83 (Retained Earnings -1.00b / Total Assets 1.20b) |
| C: -0.19 (EBIT TTM -143.8m / Avg Total Assets 762.7m) |
| D: 14.88 (Book Value of Equity 1.12b / Total Liabilities 75.6m) |
| Altman-Z'' = 14.80 = AAA |
| DSRI: 3.0 (Receivables 10.6m/1.05m, Revenue 12.4m/21.4m) |
| GMI: 1.26 (GM 83.23% / 66.27%) |
| AQI: 42.16 (AQ_t 0.47 / AQ_t-1 0.01) |
| SGI: 0.58 (Revenue 12.4m / 21.4m) |
| TATA: -0.23 (NI -368.0m - CFO -97.7m) / TA 1.20b) |
| Beneish M = 22.93 (Cap -4..+1) = D |
As of June 14, 2026, the stock is trading at USD 23.37 with a total of 26,226,159 shares traded.
Over the past week, the price has changed by -2.01%,
over one month by +9.00%,
over three months by +33.16% and
over the past year by +54.05%.
D-Wave Quantum has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy QBTS.
- StrongBuy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.4 | 55.9% |
P/S = 695.7011
P/B = 7.8488
Revenue TTM = 12.4m USD
EBIT TTM = -143.8m USD
EBITDA TTM = -137.9m USD
Long Term Debt = 35.4m USD (from longTermDebt, last quarter)
Short Term Debt = 1.69m USD (from shortTermDebt, last quarter)
Debt = 58.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.3m
Net Debt = -530.3m USD (calculated: Debt 58.1m - CCE 588.4m)
Enterprise Value = 8.13b USD (8.66b + Debt 58.1m - CCE 588.4m)
Interest Coverage Ratio = -15.02 (Ebit TTM -143.8m / Interest Expense TTM 9.57m)
EV/FCF = -23.88x (Enterprise Value 8.13b / FCF TTM -340.3m)
FCF Yield = -4.19% (FCF TTM -340.3m / Enterprise Value 8.13b)
FCF Margin = -2.73k% (FCF TTM -340.3m / Revenue TTM 12.4m)
Net Margin = -2.96k% (Net Income TTM -368.0m / Revenue TTM 12.4m)
Gross Margin = 66.27% ((Revenue TTM 12.4m - Cost of Revenue TTM 4.20m) / Revenue TTM)
Gross Margin QoQ = 63.61% (prev 64.83%)
Tobins Q-Ratio = 6.77 (Enterprise Value 8.13b / Total Assets 1.20b)
Interest Expense / Debt = 16.48% (Interest Expense 9.57m / Debt 58.1m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -113.6m (EBIT -143.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 20.19 (Total Current Assets 607.1m / Total Current Liabilities 30.1m)
Debt / Equity = 0.05 (Debt 58.1m / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 3.85 (negative EBITDA) (Net Debt -530.3m / EBITDA -137.9m)
Debt / FCF = 1.56 (negative FCF - burning cash) (Net Debt -530.3m / FCF TTM -340.3m)
Total Stockholder Equity = 835.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -48.25% (Net Income -368.0m / Total Assets 1.20b)
RoE = -44.05% (Net Income TTM -368.0m / Total Stockholder Equity 835.3m)
RoCE = -16.52% (EBIT -143.8m / Capital Employed (Equity 835.3m + L.T.Debt 35.4m))
RoIC = -9.69% (negative operating profit) (NOPAT -113.6m / Invested Capital 1.17b)
WACC = 16.14% (E(8.66b)/V(8.72b) * Re(16.16%) + D(58.1m)/V(8.72b) * Rd(16.48%) * (1-Tc(0.21)))
Discount Rate = 16.16% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.11 | Cagr: 54.45%
[DCF] Fair Price = unknown (Cash Flow -340.3m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.51 | # QB: 0
Revenue Correlation: 77.92 | Revenue CAGR: 49.32% | SUE: -0.72 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.09 | Chg30d=-6.08% | Revisions=-38% | Analysts=14
EPS next Quarter (2026-09-30): EPS=-0.08 | Chg30d=+1.87% | Revisions=-27% | Analysts=13
EPS current Year (2026-12-31): EPS=-0.31 | Chg30d=+5.42% | Revisions=+33% | GrowthEPS=-18.7% | GrowthRev=+72.5%
EPS next Year (2027-12-31): EPS=-0.38 | Chg30d=-3.97% | Revisions=+8% | GrowthEPS=-24.6% | GrowthRev=+100.9%
[Analyst] Revisions Ratio: -38%